Phase iii [december'17]
Early detection of eye diseases is key for effective treatment to reduce the onset of blindness. However, the patient’s journey to diagnosis is often long and involves many challenges. Venture Kick just awarded RetinAI with 130'000.- CHF to make eye care accessible and affordable to everyone via artificial intelligence. Link
5th international congress oct angiography [December'17]
RetinAI will be presenting the latest company's developments in this year's edition of the 5th International Congress on OCT Angiography in Rome, on the 15-16th December. Don't forget to come to our session: Unleashing the potential of longitudinal image analysis in Optical Coherence Tomography.
NVIDIA GTC munich 2017 [october'17]
RetinAI held a presentation during the last edition of the Nvidia GTC Europe in Munich, covering how ophthalmology is changing with Machine Learning. Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director) presented the efforts the company is doing to improve medical eye care around the world.
Forum EPFL - Startup Day [october'17]
RetinAI's booth on the Forum EPFL startup day received many visitors interested in the future of ophthalmology and medical eye care. Sam Stucky shared RetinAI's vision with students and showed how Artificial Intelligence (AI) will help bringing ophthalmology to those who need it the most and support current decision making pipeline in developing countries.
5th MedTech & Digital Health Forum BASEL [OCTOBER'17]
Nvidia GTC europe in munich [september'17]
RetinAI's efforts to transform ophthalmology via machine learning will be shown in this year's edition of the Nvidia GTC Europe. Don't forget to get a ticket to attend the presentation given by Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director). The talk will cover how the world of ophthalmology is changing thanks to AI and deep learning, both from a hardware and a software perspective!
EURETINA 2017 + MICCAI 2017 [august'17]
RetinAI is getting ready for a September full of conferences and events! September 7-10th we will be in the 17th EURETINA Congress in Barcelona, followed by 4 days in MICCAI'2017 in Quebec. In Canada we will present our work on automatic segmentation of pathological retinal layers and participate in this year's edition of the RETOUCH challenge.
VENTURE KICK PHASE II [July'17]
CTI Coaching Acceptance Phase III [June'17]
RetinAI is awarded with a Swiss CTI Grant [May'17]
Venture TOP25 [May'17]
ARVO 2017, Baltimore [May'17]
Our team members travelled to the American Research in Vision and Ophthalmology (ARVO) conference 2017, in Baltimore, to present their products in the field of OCT image analisys and Fundus Imaging. Many new collaborations coming along after this week!
CTI SATW Grant [April'17]
RetinAI in collaboration with the OTL (ARTORG Center, UniBern) recently received a Swiss grant to bring forward the study of ocular diseases such as Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR) and Glaucoma.
MICCAI 2017 [Feb'17]
Several submissions from the RetinAI team to MICCAI 2017. Hopefully meeting everybody in Quebec!
CTI Coaching [Dec'16]
RetinAI Medical has been selected to continue to the next phase of CTI Coaching, an initiative proposed by the swiss goverment to support promising start-ups in a variety of innovative fields.
Ypsomed Innovation PriCE 2016 Finalist [Dec'16]
Every two years, Ypsomed organizes a start-up competition to attract the attention of the most interesting start-ups in the region of Bern.
RETINET : Automatic AMD identification in OCT volumetric data [Oct'16]
Our new approach for achieving human level performance in the evaluation of AMD in OCT scans using convolutional neural network (CNNs) is out!